Current location:style >>
The cancer drugs that could improve survival rates if given to patients in the morning
style858People have gathered around
IntroductionGiving cancer patients immunotherapy early in the morning rather than in the afternoon could improve ...
Giving cancer patients immunotherapy early in the morning rather than in the afternoon could improve survival rates.
A study has found that people with terminal lung or skin cancers lived twice as long if they received immunotherapy drugs — which help the immune system destroy cancer cells — at the start of the day instead of after lunchtime.
The best results were seen in those treated at about 7.30am. They lived on average another two-and-a-half years.
The researchers who led the trial, published in the European Journal of Cancer, think this may be due to the immune system being more active very early in the day.
Previous studies found there are higher levels of immune cells circulating in the blood in the early morning.
Giving cancer patients immunotherapy early in the morning rather than in the afternoon could improve survival rates, a new study has found (Stock Image)
Immunotherapy drugs stop the proteins from binding to T-cells, effectively turning the immune system back on, enabling it to seek and destroy cancerous growths. Pictured: A graphic showing cancer cells
As well as fighting off viruses and bacteria, these can attack cancer cells.
It's thought this is due to the circadian rhythm — our body clock — getting the immune system ready to face any daytime threats from infectious agents, such as in food or transmitted via interacting with people around us.
READ MORE: Alarm over insulin shortage as Brits battling type 1 diabetes fear they'll 'die within days' without access to life-saving drug
AdvertisementImmunotherapy drugs, such as ipilimumab, pembrolizumab and nivolumab, have transformed cancer care in the UK over the past decade or so.
Since 2011 when the first immunotherapy drugs were licensed in the UK for the treatment of malignant melanoma (the most dangerous form of skin cancer), average survival time has risen from six months to five years or more.
Most of these drugs — which can cost up to £100,000 per patient per year — work by attaching to a protein called PD-L1, which is produced in large quantities by cancer cells.
The protein switches off T-cells, defender cells released by the immune system, rendering them unable to attack the cancer.
Immunotherapy drugs stop the proteins from binding to T-cells, effectively turning the immune system back on, enabling it to seek and destroy cancerous growths.
The theory is that giving immunotherapy at the start of the day would supercharge this response, as there are more T-cells circulating then.
This follows previous research that showed people given the flu vaccine early in the day produced much higher levels of antibodies than those given the jab later.
Again, the thinking is that the immune system is more active then, so responds much more vigorously to vaccines.
The researchers, from a number of bodies in France — including the PSL Research University in Paris — analysed data from 361 patients with lung or skin cancer that had spread and who were treated with immunotherapy drugs between 2015 and 2021.
Their survival rates were compared with the usual time each patient received treatment — most had roughly the same slot every week or two weeks.
The theory is that giving immunotherapy at the start of the day supercharges a person's immune response, as there are more T-cells then. Picture: Molecular model of an antibody
The results showed those treated before noon survived an average of 30 months; after that average survival was 15.9 months.
Earlier studies also involving the timing of cancer treatments reached similar conclusions.
Now two larger trials are under way in China and the U.S. to see if more lives could be saved just by giving drugs in the morning. The results are expected in the next couple of years.
Dr Pasquale Innominato, a cancer specialist at Ysbyty Gwynedd Hospital in Bangor, Wales, who is also researching the effect of earlier drug delivery, said the findings have the potential to shake-up NHS patient care.
'We need to see results from the bigger trials, but all the evidence so far shows that, whatever type of immunotherapy drug is used and whatever type of cancer it is, there are benefits from giving treatment earlier in the day.'
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“Stellar Stories news portal”。http://mauritania.downmusic.org/news-39d599440.html
Related articles
Sports betting roundup: Xander Schauffele's final putt pays off for bettors
styleXander Schauffele entered the PGA Championship with +1400 odds to win at BetMGM Sportsbook.That turn ...
【style】
Read moreA fire at a marina in Croatia destroys 22 boats, causes huge damage but no injuries
styleZAGREB, Croatia (AP) — A fire early at a marina in northwestern Croatia early Wednesday destroyed 22 ...
【style】
Read moreJokic scores 40, Nuggets shut down Edwards in 112
styleDENVER (AP) — Nikola Jokic received the Michael Jordan award from Commissioner Adam Silver before ti ...
【style】
Read more
Popular articles
- Celebrity tequila brands, like George Clooney
- A fire at a marina in Croatia destroys 22 boats, causes huge damage but no injuries
- Shopping complex fire inflicts tragedy on Vietnamese community in Poland
- French president is considering imposing a state of emergency in the territory of New Caledonia
- JoJo Siwa goes wild: Karma singer accused of getting drunk at Disney World after turning 21
- Pregnant influencer Jadé Tuncdoruk makes a daring style statement at Australian Fashion Week
Latest articles
Supreme Court declines to hear challenge to Maryland ban on rifles known as assault weapons
Christina Aguilera leaves RCA Records after spending her entire 26
Bride and groom BLASTED for giving their wedding guests 'unreasonable' list of 15 rules to follow
Report: Welding at water slide caused huge fire in Sweden that killed one person
Sports betting roundup: Xander Schauffele's final putt pays off for bettors
Italian anti
LINKS
- Lok Sabha elections 2024: Why Modi and BJP face strong resistance in south India
- Former head of one of China's top state
- Giro leader Tadej Pogacar finally takes it easy in Stage 4. Jonathan Milan takes a sprint victory
- Liberal icon Bernie Sanders is running for Senate reelection, squelching retirement rumors
- Rep. Greene and Speaker Johnson meet for a second day as possible vote on his ouster simmers
- The Titans bolster wide receiving group by adding Tyler Boyd, AP source says
- Plane passenger reveals his hilarious take on what your seat selection means about your journey
- Judge dismisses lawsuit by mother who said school hid teen's gender expression
- PGA Championship invites 7 LIV players to get top 100 in the world
- Teacher Appreciation Week: Schools subsidize on